SCHEMBL2829056

SCHEMBL2829056

CCCCCCCC(CCCC)C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.71
▸ MAPK1 P28482 1/20 0.71
▸ GRIK1 P39086 2/20 0.66
▸ GRIK2 Q13002 2/20 0.66
▸ SLC1A2 P43004 2/20 0.62
▸ SLC1A1 P43005 2/20 0.62
▸ GPR84 Q9NQS5 7/20 0.61
▸ FFAR1 O14842 1/20 0.61
▸ CHRM1 P11229 1/20 0.61
▸ AKR1A1 P14550 1/20 0.61
▸ CHRM3 P20309 1/20 0.61
▸ HTR2A P28223 1/20 0.61
▸ HTR2C P28335 1/20 0.61
▸ ADRA1A P35348 1/20 0.61
▸ HRH1 P35367 1/20 0.61
▸ DRD3 P35462 1/20 0.61
▸ SLC6A3 Q01959 1/20 0.61
▸ HDAC1 Q13547 1/20 0.61
▸ HDAC2 Q92769 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112082 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL1310131 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL112564 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL2492298 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL160269 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL538817 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL2493855 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL3004163 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL63312 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2
SCHEMBL2836840 1.00 CA2 (0.71) CA2MAPK1GRIK1GRIK2SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115433832-B Nickel and cobalt synergistic extractant and application thereof 中国科学院过程工程研究所 2024-03-19 — — CN claimed
CN-115433832-A Nickel and cobalt synergistic extraction agent and application thereof 中国科学院过程工程研究所 2022-12-06 — — CN claimed
CN-101088487-B polycondensate, preparation method thereof, cosmetic or drug composition, and use thereof OREAL 2012-10-24 — — CN claimed
US-20080069786-A1 POLYCONDENSATE, COMPOSITION, TREATMENT PROCESS, AND PREPARATION PROCESS L'OREAL (FR) 2008-03-20 — — US claimed
CN-101088487-A Cosmetic or pharmaceutical composition comprising a condensation polymer, cosmetic treatment method employing said composition, said condensation polymer and preparation method OREAL (FR) 2007-12-19 — — CN claimed
US-5736503-A High sudsing detergent compositions with specially selected soaps THE PROCTER & GAMBLE COMPANY (US) 1998-04-07 — — US claimed
EP-0670885-B1 HIGH SUDSING DETERGENT COMPOSITIONS WITH SPECIALLY SELECTED SOAPS PROCTER & GAMBLE (US) 1997-08-20 — — EP claimed
CN-1090887-A The high-sudsers composition that contains specially selected soap PROCTER & GAMBLE (US) 1994-08-17 — — CN claimed
WO-1994012608-A1 HIGH SUDSING DETERGENT COMPOSITIONS WITH SPECIALLY SELECTED SOAPS THE PROCTER & GAMBLE COMPANY (US) 1994-06-09 — — WO claimed
US-4937008-A Concentrated softening agent for use in clothings: quaternary ammonium salt, mono-ol, di- or tri-ol, inorganic salt and polyester KAO CORPORATION (JP) 1990-06-26 — — US claimed
US-12564879-B2 Copper paste for joining, method for manufacturing joined body, and joined body RESONAC CORPORATION (JP) 2026-03-03 — — US disclosed
US-20260028721-A1 METHOD FOR MANUFACTURING SUBSTRATE WITH CONDUCTIVE VIAS AND METHOD FOR MANUFACTURING WIRING BOARD WITH CONDUCTIVE VIAS RESONAC CORP (JP) 2026-01-29 — — US disclosed
US-20250387833-A1 METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE RESONAC CORP (JP) 2025-12-25 — — US disclosed
US-20250293091-A1 METHOD FOR PRODUCING SUBSTRATE HAVING THROUGH-SILICON VIAS, SUBSTRATE HAVING THROUGH-SILICON VIAS, AND COPPER PASTE FOR THROUGH-SILICON VIA FORMATION RESONAC CORPORATION (JP) 2025-09-18 — — US disclosed
EP-4618701-A1 METHOD FOR MANUFACTURING GLASS SUBSTRATE HAVING CONDUCTIVE VIA, METAL PASTE FOR FORMING THROUGH-GLASS VIA, AND GLASS SUBSTRATE HAVING CONDUCTIVE VIA Resonac Corporation (JP) 2025-09-17 — — EP disclosed
US-4937008-A Concentrated softening agent for use in clothings: quaternary ammonium salt, mono-ol, di- or tri-ol, inorganic salt and polyester KAO CORPORATION (JP) 1990-06-26 — — US disclosed
US-4806414-A THERMOPLASTIC POLYMERS WITH POLYESTER-ESTER URETHANE ADHESIVES AKZO NV (NL) 1989-02-21 — — US disclosed
US-4664807-A CHROMATOGRAPHY, RECRYSTALLIZATION DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1987-05-12 — — US disclosed
EP-0213681-A1 Composite material AKZO N.V. (NL) 1987-03-11 — — EP disclosed
EP-0053415-A1 Method of isolating sterols in commercial quantities from sterol-containing material DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1982-06-09 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387833-A1 METHOD FOR MANUFACTURING CONDUCTIVE VIA-CONTAINING SUBSTRATE, CONDUCTIVE VIA-CONTAINING SUBSTRATE, AND METAL PASTE C5, C9, CUTA CA2 2282/4885MAPK1 210/4885GRIK1 1331/4885
US-20260028721-A1 METHOD FOR MANUFACTURING SUBSTRATE WITH CONDUCTIVE VIAS AND METHOD FOR MANUFACTURING WIRING BOARD WITH CONDUCTIVE VIAS PIEZO1, CACNA1C, GJB2 CA2 1511/4885MAPK1 86/4885GRIK1 812/4885
US-12564879-B2 Copper paste for joining, method for manufacturing joined body, and joined body DCX, DNAJA2, DNAJA1 CA2 4461/4885MAPK1 3048/4885GRIK1 2953/4885
US-20080069786-A1 POLYCONDENSATE, COMPOSITION, TREATMENT PROCESS, AND PREPARATION PROCESS POLR1C, PIK3C3, SUV39H2 CA2 336/4885MAPK1 1787/4885GRIK1 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback